AICD Indications     body {font-family: 'Open Sans', sans-serif;}

### AICD Indications

 ≤ 35% due to patients who have had a prior MI and are at least 40 days post-MI 

LV dysfunction due to prior MI at least 40 days post-MI and have an LVEF ≤ 30%. 

Survivor of sudden cardiac arrest due to ventricular fibrillation (VF) after evaluation to define the cause of the event and to exclude any completely reversible causes.

Non-ischemic Dilated Cardiomyopathy (DCM) who have an LVEF ≤ 35%. 

Nonsustained  V-tach due to prior MI, LVEF < 40%, and inducible ventricular fibrillation or sustained ventricular tachycardia at electrophysiological study.

Structural heart disease and spontaneous sustained VT, whether hemodynamically stable or unstable.

Syncope of undetermined origin with clinically relevant, hemodynamically significant sustained VT or VF induced at electrophysiological study.

Barash, Paul G. _Clinical Anesthesia_. Philadelphia, PA: Wolters Kluwer, 2009  
  
**"Guidelines for Cardiac Pacing and Cardiac Resynchronization Therapy:** **The Task Force for Cardiac Pacing and Cardiac Resynchronization Therapy of the European Society of Cardiology**. Developed in Collaboration with the European Heart Rhythm Association."_Europace_ 9.10 (2007): 959 - 98  
  
Perioperative Management of AICD/PACER; The Student Doctor Network-cardiology.  
  
Tidy, Colin. "Patient.Co.UK." _Pacemakers and Pacing_ 22 (2010)  
  
Trohman, R., M. Kim, and S. Pinski. "Cardiac Pacing: The State of the Art." _The Lancet_364.9446 (2004): 1701 - 719.  
Wallace, Arthur. "Pacemakers for Anesthesiologists Made Incredibly Simple." (2008)